The forthcoming RSV shot, expected to get US regulatory approval this month, is Moderna’s first chance to show the versatility of mRNA technology to more effectively treat and prevent a range of illnesses from the flu to cancer.
The post Moderna’s mRNA dreams meet reality with first post-Covid shot appeared first on Boston.com…
Source : The Boston Globe